Martin 2
manipulation of the DNA within an organism. This technology has existed for less than
50 years.
The first use of Genetic engineering happened in 1972 when Dr. Paul Berg
combined DNA from two different viruses to make a hybrid of those viruses (Jackson,
Simons, Berg). In 1960, Dr. P.G. Katsoyannis, a scientist at the University of Pittsburgh,
discovered the genetic makeup of insulin. Within two years of his discovery, he was
able to artificially reproduce the insulin. This was the first time that human insulin was
produced synthetically within a lab. This breakthrough in science had a widely positive
reaction because of the medical upside it had. The ability to produce “human” insulin
allowed the product to be more widely available and cost effective. Before this the only
way to make insulin was to extract it from the pancreas of an animal. After extraction the
insulin still needed to be altered before it could be used within a human body (Stretton).
In 1976, Genentech Inc. became the first company to mass-produce a genetically
engineered product for human use. This product was insulin used to treat type I and II
diabetes. After years of strict testing and research to meet government regulation, this
insulin was made available for sale in 1982. This made the synthetic insulin the first
genetically engineered product available for purchase. Another genetically engineered
product became available for commercial purchase about 12 years later, but this
product was not nearly as successful as its predecessor. This product was the Flavr
Savr tomato. The Flavr Savr tomato was engineered so the enzyme which causes a
tomato to become soft and rot, could no longer be produced by the plant. Though this
was a significant breakthrough in science, the general public was not comfortable with